| scholarly article | Q13442814 |
| P2093 | author name string | Changxin Wu | |
| Jianguo Li | |||
| Xuemei Qin | |||
| Cui Wang | |||
| Xueyang Jia | |||
| Luwen Hou | |||
| P2860 | cites work | Investigation on the antidepressant effect of sea buckthorn seed oil through the GC-MS-based metabolomics approach coupled with multivariate analysis. | Q50569855 |
| 1H NMR-based urinary metabolic profiling reveals changes in nicotinamide pathway intermediates due to postnatal stress model in rat. | Q51107962 | ||
| Metabolomics and Lipidomics Study of Mouse Models of Type 1 Diabetes Highlights Divergent Metabolism in Purine and Tryptophan Metabolism Prior to Disease Onset. | Q52469469 | ||
| Application of dynamic metabolomics to examine in vivo skeletal muscle glucose metabolism in the chronically high-fat fed mouse. | Q53520964 | ||
| Different effects of intranigral and intrastriatal administration of the proteasome inhibitor lactacystin on typical neurochemical and histological markers of Parkinson's disease in rats. | Q68011659 | ||
| Agmatine produces antidepressant-like effects in two models of depression in mice. | Q42673618 | ||
| Current Status of Ketamine and Related Therapies for Mood and Anxiety Disorders | Q43086364 | ||
| Gut microbiome-derived metabolites characterize a peculiar obese urinary metabotype. | Q43138002 | ||
| Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant | Q43534797 | ||
| Different action on dopamine catabolic pathways of two endogenous 1,2,3,4-tetrahydroisoquinolines with similar antidopaminergic properties | Q43658596 | ||
| A novel urinary metabolite signature for diagnosing major depressive disorder | Q43827823 | ||
| Fluvoxamine, a selective serotonin reuptake inhibitor, suppresses tetrahydrobiopterin levels and dopamine as well as serotonin turnover in the mesoprefrontal system of mice | Q45004467 | ||
| Variations in gut microbiota and fecal metabolic phenotype associated with depression by 16S rRNA gene sequencing and LC/MS-based metabolomics | Q46414968 | ||
| A fully validated GC-TOF-MS method for the quantification of fatty acids revealed alterations in the metabolic profile of fatty acids after smoking cessation | Q46438396 | ||
| Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism | Q46565524 | ||
| Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder | Q46767416 | ||
| Dynamic Metabolomics Reveals that Insulin Primes the Adipocyte for Glucose Metabolism | Q47270761 | ||
| Sodium butyrate triggers a functional elongation of microglial process via Akt-small RhoGTPase activation and HDACs inhibition | Q47285298 | ||
| Integrated Metabolomics and Proteomics Analysis of Hippocampus in a Rat Model of Depression | Q47296764 | ||
| Estimation of time-varying growth, uptake and excretion rates from dynamic metabolomics data | Q47322280 | ||
| Plasma-metabolite-biomarkers for the therapeutic response in depressed patients by the traditional Chinese medicine formula Xiaoyaosan: A (1)H NMR-based metabolomics approach | Q47394787 | ||
| The identification of metabolic disturbances in the prefrontal cortex of the chronic restraint stress rat model of depression | Q47444989 | ||
| Glycyrrhizic acid ameliorates the kynurenine pathway in association with its antidepressant effect. | Q47552282 | ||
| Dynamic analysis of the endogenous metabolites in depressed patients treated with TCM formula Xiaoyaosan using urinary (1)H NMR-based metabolomics | Q47583527 | ||
| Sodium Butyrate, a Histone Deacetylase Inhibitor, Reverses Behavioral and Mitochondrial Alterations in Animal Models of Depression Induced by Early- or Late-life Stress | Q47628480 | ||
| Metabolite identification in fecal microbiota transplantation mouse livers and combined proteomics with chronic unpredictive mild stress mouse livers | Q47642189 | ||
| Agmatine attenuates chronic unpredictable mild stress induced behavioral alteration in mice | Q47834788 | ||
| Peripheral administration of lactate produces antidepressant-like effects | Q48038974 | ||
| A Novel Urinary Metabolite Signature for Non-invasive Post-stroke Depression Diagnosis | Q48050618 | ||
| Antidepressant-like effects of sodium butyrate and its possible mechanisms of action in mice exposed to chronic unpredictable mild stress | Q48061638 | ||
| Metabolite signature for diagnosing major depressive disorder in peripheral blood mononuclear cells | Q48064073 | ||
| Antidepressant-like effects of oleoylethanolamide in a mouse model of chronic unpredictable mild stress | Q48085858 | ||
| In vivo study on the neurotransmitters and their metabolites change in depressive disorder rat plasma by ultra high performance liquid chromatography coupled to tandem mass spectrometry | Q48101685 | ||
| Suppressive effect of paroxetine, a selective serotonin uptake inhibitor, on tetrahydrobiopterin levels and dopamine as well as serotonin turnover in the mesoprefrontal system of mice | Q48141961 | ||
| Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse | Q48432006 | ||
| Antidepressant-like effect of sodium butyrate (HDAC inhibitor) and its molecular mechanism of action in the rat hippocampus. | Q48818809 | ||
| Metabonomic study on chronic unpredictable mild stress and intervention effects of Xiaoyaosan in rats using gas chromatography coupled with mass spectrometry. | Q48835087 | ||
| Gut microbiome and depression: what we know and what we need to know. | Q49350790 | ||
| Profound changes in dopaminergic neurotransmission in the prefrontal cortex in response to flattening of the diurnal glucocorticoid rhythm: implications for bipolar disorder | Q28583351 | ||
| Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour | Q29617115 | ||
| Cellular and molecular basis for stress-induced depression | Q30836590 | ||
| ANOVA-simultaneous component analysis (ASCA): a new tool for analyzing designed metabolomics data | Q30989683 | ||
| The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment | Q33593061 | ||
| Novel urinary metabolite signature for diagnosing postpartum depression | Q33704082 | ||
| An investigation of the antidepressant action of xiaoyaosan in rats using ultra performance liquid chromatography-mass spectrometry combined with metabonomics | Q34414219 | ||
| Linking molecules to mood: new insight into the biology of depression | Q34540304 | ||
| Developments in the field of antidepressants, where do we go now? | Q34652241 | ||
| Relationship of neurotransmitters to the symptoms of major depressive disorder. | Q34780174 | ||
| Antidepressant-like effect of sodium butyrate is associated with an increase in TET1 and in 5-hydroxymethylation levels in the Bdnf gene. | Q35203658 | ||
| The gut microbiome and diet in psychiatry: focus on depression | Q35442662 | ||
| MetaboAnalyst 3.0--making metabolomics more meaningful | Q35610559 | ||
| Metabolic Effects of a 24-Week Energy-Restricted Intervention Combined with Low or High Dairy Intake in Overweight Women: An NMR-Based Metabolomics Investigation | Q35933016 | ||
| Microbiome-Gut-Brain Axis: Probiotics and Their Association With Depression | Q36107604 | ||
| Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis | Q36118736 | ||
| (13)C-tryptophan breath test detects increased catabolic turnover of tryptophan along the kynurenine pathway in patients with major depressive disorder. | Q36241987 | ||
| Identification and validation of urinary metabolite biomarkers for major depressive disorder | Q36508139 | ||
| The rapid antidepressant effect of ketamine in rats is associated with down-regulation of pro-inflammatory cytokines in the hippocampus | Q36754254 | ||
| Metabolomics tools for identifying biomarkers for neuropsychiatric diseases | Q37419784 | ||
| HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition | Q37647371 | ||
| Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease | Q38161223 | ||
| Depression: from psychopathology to pathophysiology | Q38248863 | ||
| Toward Omics-Based, Systems Biomedicine, and Path and Drug Discovery Methodologies for Depression-Inflammation Research | Q38454097 | ||
| NMR and MS Methods for Metabolomics | Q38658442 | ||
| Emerging applications of metabolomics in drug discovery and precision medicine | Q38769103 | ||
| Targeting the Microbiota-Gut-Brain Axis: Prebiotics Have Anxiolytic and Antidepressant-like Effects and Reverse the Impact of Chronic Stress in Mice. | Q38939164 | ||
| Rapid Antidepressant Effect of Hydrogen Sulfide: Evidence for Activation of mTORC1-TrkB-AMPA Receptor Pathways | Q38980422 | ||
| Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach | Q38985361 | ||
| Potential antidepressant and resilience mechanism revealed by metabolomic study on peripheral blood mononuclear cells of stress resilient rats | Q39300330 | ||
| IDO chronic immune activation and tryptophan metabolic pathway: A potential pathophysiological link between depression and obesity. | Q39360365 | ||
| Purine metabolism is dysregulated in patients with major depressive disorder | Q39788582 | ||
| Metabolic Dysregulation Induced in Plasmodium falciparum by Dihydroartemisinin and Other Front-Line Antimalarial Drugs | Q41119883 | ||
| Short overview on metabolomic approach and redox changes in psychiatric disorders. | Q41791000 | ||
| Early Effect of Amyloid β-Peptide on Hippocampal and Serum Metabolism in Rats Studied by an Integrated Method of NMR-Based Metabolomics and ANOVA-Simultaneous Component Analysis. | Q42323524 | ||
| From Serotonin to Neuroplasticity: Evolvement of Theories for Major Depressive Disorder | Q42369081 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 454 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Frontiers in Psychiatry | Q27723495 |
| P1476 | title | Short Term Intrarectal Administration of Sodium Propionate Induces Antidepressant-Like Effects in Rats Exposed to Chronic Unpredictable Mild Stress | |
| P478 | volume | 9 |
| Q102075423 | Intravenous administration of sodium propionate induces antidepressant or prodepressant effect in a dose dependent manner |
| Q92136357 | Optimization of food deprivation and sucrose preference test in SD rat model undergoing chronic unpredictable mild stress |
Search more.